Stay updated with breaking news from Analytical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Novavax, Inc. (NASDAQ: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
CPhI Worldwide welcomes attendees back to the show floor in person this month. We put the spotlight on some of the exhibitors who will be there.
Scientists developing chimeric antigen receptor (CAR) T cell products strive to maximize specificity, potency, and persistence of these therapies, but the inability to predict treatment efficacy and response remains a significant challenge. Daniel Hui, PhD, Associate Director of Analytical Development at Tmunity Therapeutics, addresses these challenges and highlights the company’s multiplatform approach to build an innovative “toolbox” of orthogonal assays to provide a comprehensive set of data to characterize CAR-T cell therapeutic products.
Given the rapid emergence of gene therapies based on recombinant adeno-associated virus (rAAV), there is a great need for appropriate analytical...
YEREVAN, OCTOBER 7, ARMENPRESS. Eugene Chausovsky, Consultant with the Analytical Development department and a Non-Resident Fellow at the Washington, D.C.-based Newlines Institute think-tank, says the gradual resumption of the OSCE Minsk Group negotiation process and the resumption of the Armenian-Azerbaijani dialogue over the Karabakh issue within the Minsk Group are a positive signal, however he doesn’t expect major changes from the Minsk process.